Pyridostigmine Bromide
NDC 42192-626, pyridostigmine bromide, solution, from Acella Pharmaceuticals, LLC.
- Product NDC
- 42192-626
- Status
- Listed
- Labeler
- Acella Pharmaceuticals, LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212405
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42192-626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PYRIDOSTIGMINE BROMIDE60 mg/5mL
Pharmacologic classes
Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42192-626-16 | 42192062616 | 473 mL in 1 BOTTLE (42192-626-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/56999559-274e-44ea-a317-29366fdca908NADAC price for package 42192062616
GET /v1/drugs/nadac/42192062616
Use it
Look up 42192-626 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42192-626 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42192-626. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.